- Home
- NKTX
NKTX
Nkarta Inc.
as 05-17-2024 4:00pm EST
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 484.8M | IPO Year: | 2020 |
| Target Price: | $17.50 | AVG Volume (30 days): | 1.0M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.35 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.28 - $16.24 | Next Earning Date: | 05-09-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Share on Social Networks:
Stock Insider Trading Activity of Nkarta Inc. (NKTX)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | NKTX | Director10% Owner | Mar 27 '24 | Buy | $10.00 | 3,000,000 | $30,000,000.00 | 10,050,818 | SEC Form 4 |
| George Simeon | NKTX | Director | Mar 27 '24 | Buy | $10.00 | 1,548,341 | $15,483,410.00 | 1,548,341 | SEC Form 4 |
| George Simeon | NKTX | Director | Mar 27 '24 | Buy | $10.00 | 451,659 | $4,516,590.00 | 451,659 | SEC Form 4 |
| Brandenberger Ralph | NKTX | Chief Technical Officer | Mar 1 '24 | Sell | $12.51 | 8,367 | $104,671.17 | 79,972 | SEC Form 4 |
Latest Nkarta Inc. News
NKTX Breaking Stock News: Dive into NKTX Ticker-Specific Updates for Smart Investing
Simply Wall St.
9 days ago
Nkarta (NASDAQ:NKTX) Is In A Good Position To Deliver On Growth Plans
GuruFocus.com
9 days ago
Nkarta Inc (NKTX) Reports Q1 2024 Earnings: A Detailed Financial and Operational Analysis
GlobeNewswire
10 days ago
Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights
GlobeNewswire
2 months ago
Nkarta to Participate in Upcoming Investor Conferences
Investor's Business Daily
2 months ago
Why Nkarta Stock Just Boomeranged Following A Massive Dive On Friday
GlobeNewswire
2 months ago
Nkarta Announces Pricing of $240 Million Underwritten Offering
GuruFocus.com
2 months ago
Nkarta Inc (NKTX) Posts Full Year 2023 Financial Results: A Focus on NKX019 and Pipeline Realignment
Investor's Business Daily
2 months ago